Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NACL Industries Limited (NACLIND.NS)
Hyderabad, IN
Established in 1986 and headquartered in Hyderabad, India, NACL Industries Limited is a key player in the agricultural chemicals sector. The company develops and markets a wide array of products, including various active ingredients such as myclobutanil, propiconazole, profenofos, tricyclazole, and pretilachlors. Additionally, its offerings encompass diverse formulated solutions like insecticides, fungicides, herbicides, plant growth regulators, nematicides, pesticides, and acaricides. NACL also extends its expertise through contract manufacturing services for several international companies. Its products reach consumers in India via a network of retail partners and are exported to roughly 30 countries globally. Originally incorporated as Nagarjuna Agrichem Limited, the company adopted its current name, NACL Industries Limited, in September 2017. It operates as a subsidiary of KLR Products Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.58% | -2.93% | +1.95% | +18.40% | -3.55% | -4.01% | -15.08% | +59.92% | +206.73% | +403.04% | +403.04% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Agricultural Inputs: +9.5%+28.4% ★ Q1'26: +79.2% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+104.5% ★ Q1'26: +98.4% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%-14.2% Q1'26: -28.4% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+4.5% Q1'26: +1.2% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+4.4% Q1'26: +1.3% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+9.3% Q1'26: +8.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×3.03× Q1'26: 5.88× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
|---|---|
| Revenue |
7.46B
est: 7.50B (-0.6%)
|
| EBITDA |
699.76M
est: 423.69M (+65.2%)
|
| EBIT |
404.42M
est: 290.77M (+39.1%)
|
| Net Income |
83.46M
est: 121.83M (-31.5%)
|
| SGA |
915.63M
est: 556.28M (+64.6%)
|
| EPS |
0.54
est: 0.61 (-11.8%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Biju Pillai | Director & Head of R&D | — | — |
| C. R. Sriniwas | CHRO & Senior Vice President of Human Potential Development & Admin | — | male |
| Harish Chandra Bijlwan | Senior Vice President of Operations & Technology | — | male |
| J. Satyanarayana Das | Vice President of Manufacturing - Ethakota Plant | — | male |
| Kuppusamy | Vice President & Head of Product Development, IPR & Regulatory Affairs | — | — |
| Manikkam Natarajan | Executive Vice President of Marketing & Sales | — | male |
| N. R. Vishwanathan | Head of Human Resources & Admin | — | male |
| N. Shankar | Chief Financial Officer | — | male |
| Narasimha Rao Kothapalli | Senior Vice President of Exports | — | male |
| Praveen Kumar Dubey | VP & Head of Institutional Business Strategic Sourcing | — | male |
| Raghuram Devarakonda | Chief Executive Officer, MD & Director | — | — |
| Rajesh Mukhija | Company Secretary & Compliance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NACLIND.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
